Gangtok Chronicle

Pneumonia Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market

 Breaking News
  • No posts were found

Pneumonia Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market

December 05
17:05 2022
Pneumonia Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market
DelveInsight Business Research LLP
DelveInsight’s “Pneumonia Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Pneumonia, historical and forecasted epidemiology as well as the Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight’s Pneumonia Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Pneumonia, historical and forecasted epidemiology as well as the Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Pneumonia market report provides current treatment practices, emerging drugs, Pneumonia market share of individual therapies, and current and forecasted Pneumonia market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Pneumonia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities. It assesses the underlying potential of the Pneumonia market.

Some of the key facts of the Pneumonia Market:

  • Pneumonia accounts for 14% of all deaths of children under 5 years old, killing 740 180 children in 2019.

  • Pneumonia is the single largest infectious cause of death in children worldwide. Pneumonia killed 740 180 children under the age of 5 in 2019, accounting for 14% of all deaths of children under 5 years old but 22% of all deaths in children aged 1 to 5 years.

Got queries? Click here to know more about the Pneumonia Market Landscape

 

Pneumonia Overview

Pneumonia is a form of acute respiratory infection that affects the lungs. The lungs are made up of small sacs called alveoli, which fill with air when a healthy person breathes. When an individual has pneumonia, the alveoli are filled with pus and fluid, which makes breathing painful and limits oxygen intake.

 

Pneumonia  Epidemiology Insights

  • The estimated worldwide incidence of community-acquired pneumonia varies between 1.5 to 14 cases per 1000 person-years, and this is affected by geography, season, and population characteristics. In the United States, the annual incidence is 24.8 cases per 10,000 adults with higher rates as age increases. Pneumonia is the eighth leading cause of death and first among infectious causes of death. The mortality rate is as high as 23% for patients admitted to the intensive care unit. 

 

Pneumonia Epidemiology Segmentation

 

  •  Total Pneumonia prevalent cases 

  • Total Pneumonia age-specific cases 

  • Total Pneumonia treatment-specific cases 

  • Total Pneumonia diagnosed-specific cases 

 

Pneumonia Market Outlook 

The Pneumonia market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Pneumonia market trends by analyzing the impact of current Pneumonia therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Pneumonia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Pneumonia market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Pneumonia market in 7MM is expected to witness a major change in the study period 2019-2032.

 

Learn more by requesting for sample @ Pneumonia  Market Trends

 

 

Pneumonia Key Companies 

  • Bayer 

  • Roche 

  • Pfizer 

  • Nektar Pharma 

  • AstraZeneca 

  • TaiGen Pharma 

  • And many others 

 

Pneumonia Therapies

 

  • Amikacin inhalation solution-  (BAY41-6551)

  • Doripenem

  • Levofloxacin

  • Lanadelumab

  • Remdesivir

  • Tocilizumab

  • And many others 

 

Table of Contents

 

  1.   Key Insights 

  2.  Report Introduction 

  3.  Executive Summary of Pneumonia   

  4.  Disease Background and Overview

  5.  Epidemiology and patient population

  6.  The United States 

  7.  EU 5

  8.  Pneumonia Emerging Therapies

  9.  Pneumonia Market Outlook

  10.  Market Access and Reimbursement of Therapies

  11.  Market Drivers 

  12.  Market Barriers 

  13.  Appendix

  14.  Pneumonia Report Methodology

  15.  DelveInsight Capabilities

  16.  Disclaimer

Click here to read more about Pneumonia Market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com